Farallon Capital Management’s Iovance Biotherapeutics IOVA Stock Holding History

Farallon Capital Management’s Portfolio IOVA Stock Details IOVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$91.3K	Hold	26,000	–	–	﹤0.01%	160
2025 Q4	$71K	Hold	26,000	–	–	﹤0.01%	146
2025 Q3	$56.4K	Hold	26,000	–	–	﹤0.01%	139
2025 Q2	$44.7K	Hold	26,000	–	–	﹤0.01%	139
2025 Q1	$86.6K	Hold	26,000	–	–	﹤0.01%	137
2024 Q4	$192K	Hold	26,000	–	–	﹤0.01%	132
2024 Q3	$244K	Hold	26,000	–	–	﹤0.01%	129
2024 Q2	$209K	Hold	26,000	–	–	﹤0.01%	135
2024 Q1	$385K	Sell	26,000 -536,000	-95%	-$6.24M	﹤0.01%	126
2023 Q4	$4.57M	Buy	+562,000	New	+$2.94M	0.03%	93
2022 Q3	–	Sell	-3,176,773	Closed	-$35.1M	–	317
2022 Q2	$35.1M	Sell	3,176,773 -2,998,584	-49%	-$39.3M	0.21%	78
2022 Q1	$103M	Buy	6,175,357 +113,384	+2%	+$1.75M	0.57%	50
2021 Q4	$116M	Buy	6,061,973 +721,979	+14%	+$15.9M	0.65%	44
2021 Q3	$132M	Buy	5,339,994 +89,994	+2%	+$2.12M	0.71%	47
2021 Q2	$137M	Buy	5,250,000 +500,000	+11%	+$13M	0.66%	46
2021 Q1	$150M	Sell	4,750,000 -1,250,000	-21%	-$51.8M	0.78%	39
2020 Q4	$278M	Buy	6,000,000 +45,000	+0.8%	+$1.79M	1.73%	25
2020 Q3	$196M	Sell	5,955,000 -582,500	-9%	-$17.9M	1.39%	28
2020 Q2	$179M	Buy	6,537,500 +787,500	+14%	+$25.9M	1.44%	27
2020 Q1	$172M	Sell	5,750,000 -500,000	-8%	-$13.3M	1.58%	25
2019 Q4	$173M	Buy	6,250,000 +225,000	+4%	+$5.12M	1.33%	30
2019 Q3	$110M	Buy	6,025,000 +300,000	+5%	+$6.63M	0.9%	30
2019 Q2	$140M	Hold	5,725,000	–	–	0.98%	30
2019 Q1	$54.4M	Hold	5,725,000	–	–	0.45%	50
2018 Q4	$50.7M	Buy	5,725,000 +1,000,000	+21%	+$9.64M	0.44%	46
2018 Q3	$53.2M	Buy	4,725,000 +300,000	+7%	+$4.26M	0.37%	49
2018 Q2	$56.6M	Buy	4,425,000 +275,000	+7%	+$4.02M	0.42%	48
2018 Q1	$70.1M	Buy	4,150,000 +2,283,100	+122%	+$34.6M	0.59%	43
2017 Q4	$14.9M	Buy	1,866,900 +1,016,900	+120%	+$8.16M	0.15%	61
2017 Q3	$6.59M	Buy	+850,000	New	+$5.38M	0.07%	77